Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atrial Fibrillation in the Elderly.

Asim Yunus1, George Wyse

  • 1Division of Cardiology, Foothills Hospital and University of Calgary, Calgary, Alberta, Canada.

The American Journal of Geriatric Cardiology
|October 1, 1995
PubMed
Summary

Atrial fibrillation (AF) is common in older adults and increases stroke risk. Maintaining sinus rhythm or controlling heart rate is crucial, with individualized antithrombotic therapy needed for those over 75.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BioMonitor 2 in-office setting insertion safety and feasibility evaluation with device functionality assessment: results from the prospective cohort BioInsight study.

BMC cardiovascular disorders·2020
Same author

Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design.

The Canadian journal of cardiology·2019
Same author

Conductor externalization in a Riata ST Optim™ lead.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2013
See all related articles

Area of Science:

  • Cardiology
  • Geriatrics
  • Internal Medicine

Background:

  • Atrial fibrillation (AF) is a prevalent cardiac arrhythmia, particularly in individuals over 65, affecting up to 5% of this demographic.
  • Advancing age is a significant risk factor for developing AF and its associated complications, including stroke and left ventricular dysfunction.
  • The elderly population exhibits reduced tolerance to the hemodynamic stress associated with new-onset and rapid AF.

Purpose of the Study:

  • To highlight the importance of sinus rhythm in mitigating thromboembolic risks in elderly patients with atrial fibrillation.
  • To discuss the benefits of heart rate control when sinus rhythm cannot be maintained.
  • To review antithrombotic strategies for elderly patients with atrial fibrillation, considering age-specific benefits and risks.

Main Methods:

  • Literature review of recent trials on atrial fibrillation management in the elderly.
  • Analysis of epidemiological data on AF prevalence and risk factors in older adults.
  • Evaluation of pharmacological and non-pharmacological interventions for rate and rhythm control.

Main Results:

  • Sinus rhythm is paramount for reducing thromboembolic risks in elderly patients with AF.
  • Pharmacological or other means of heart rate control offer benefits when sinus rhythm restoration is not feasible.
  • Established benefits of aspirin and warfarin may not universally apply to patients over 75, necessitating individualized antithrombotic approaches.

Conclusions:

  • Maintaining sinus rhythm is a key strategy for managing atrial fibrillation in the elderly.
  • Heart rate control is an important alternative when sinus rhythm cannot be achieved or sustained.
  • Individualized antithrombotic therapy is essential for elderly patients with atrial fibrillation, especially those over 75, due to varying treatment efficacies.

Related Experiment Videos